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Abstract
Background: Traditional high volume aerobic exercise training reduces cardiovascular and
metabolic disease risk but involves a substantial time commitment. Extremely low volume high-
intensity interval training (HIT) has recently been demonstrated to produce improvements to
aerobic function, but it is unknown whether HIT has the capacity to improve insulin action and
hence glycemic control.
Methods: Sixteen young men (age: 21 ± 2 y; BMI: 23.7 ± 3.1 kg·m-2; VO2peak: 48 ± 9 ml·kg-1·min-
1) performed 2 weeks of supervised HIT comprising of a total of 15 min of exercise (6 sessions; 4–
6 × 30-s cycle sprints per session). Aerobic performance (250-kJ self-paced cycling time trial), and
glucose, insulin and NEFA responses to a 75-g oral glucose load (oral glucose tolerance test;
OGTT) were determined before and after training.
Results: Following 2 weeks of HIT, the area under the plasma glucose, insulin and NEFA
concentration-time curves were all reduced (12%, 37%, 26% respectively, all P < 0.001). Fasting
plasma insulin and glucose concentrations remained unchanged, but there was a tendency for
reduced fasting plasma NEFA concentrations post-training (pre: 350 ± 36 v post: 290 ± 39 μmol·l-
1, P = 0.058). Insulin sensitivity, as measured by the Cederholm index, was improved by 23% (P <
0.01), while aerobic cycling performance improved by ~6% (P < 0.01).
Conclusion: The efficacy of a high intensity exercise protocol, involving only ~250 kcal of work
each week, to substantially improve insulin action in young sedentary subjects is remarkable. This
novel time-efficient training paradigm can be used as a strategy to reduce metabolic risk factors in
young and middle aged sedentary populations who otherwise would not adhere to time consuming
traditional aerobic exercise regimes.
Background
The prevalence of type 2 diabetes (T2D) is rapidly increas-
ing world-wide and, for example, in the United States it
reached 17.5 million people in 2007 [1]. Aside from the
associated reduction in quality-of-life and the increase in
morbidity and mortality for the affected individuals, the
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medical expenditures and $58 billion in reduced produc-
tivity [1]. Similarly, the estimated direct and indirect eco-
nomic costs of cardiovascular disease (CVD) in the US for
2008 are estimated at $287 billion [2].
The risk of developing CVD and T2D can be modified by
regular physical activity [3]. However, there is no consen-
sus on the nature of exercise therapy required to provide
adequate health benefits, particularly with regard to the
volume-intensity relationship. Furthermore, as we do not
understand the precise mechanisms which link physical
activity and a reduced risk of developing CVD or T2D, the
scientific rationale for current health guides needs to be
improved [4]. For exercise guidelines to yield a positive
economic benefit for society, as well as a health benefit for
the individual, not only should the regime reliably mod-
ify key disease risk factors, it must also be plausible to
implement.
Metabolic adaptations associated with traditional aerobic
exercise training correlate with improved insulin action
and glycemic control [5,6]. These effects appear to be
independent of changes in body composition [7], and
some evidence suggests that greater improvements in
insulin sensitivity may be achieved with higher training
intensities [8-10]. Current recommendations for improv-
ing glycemic control involve performing moderate to vig-
orous intensity aerobic and resistance exercise for several
hours per week [11,12]. However, the general population
fails to follow such regimes due to lack of time, motiva-
tion and adherence [13]. This suggests that the current
focus on time-consuming moderate intensity physical
activity, aimed at increasing total energy expenditure, may
not be optimal for reducing the risk of developing T2D.
Recently an extremely low volume high-intensity interval
training paradigm (HIT), consisting of no more than 7.5
minutes of exercise per week, has been proposed as a
novel, time-efficient exercise regime for improving aero-
bic fitness [4,14]. We speculated that it should be possible
to substantially improve insulin action using HIT despite
a negligible contribution to total energy expenditure as
this training model would substantially reduce muscle
glycogen stores. Compared to traditional strategies for
reduction of risk factors of CVD and T2D, the extremely
low volume of exercise required with HIT may promote
adherence and thus represent a genuinely preventative
public health strategy.
Methods
Subjects
Twenty-five young healthy sedentary or recreationally
active men were recruited to participate in this study, with
none engaged in a structured endurance training program.
Subjects were randomly allocated to one of two parts of
the study. Sixteen subjects (mean ± SD: 21 ± 2 y; 82 ± 17
kg; 1.83 ± 0.08 m; BMI: 23.7 ± 3.1 kg·m-2; VO2max: 48 ±
9 ml·kg-1·min-1) were allocated to the main part of the
study, and completed the full experimental procedures.
The remaining nine subjects (mean ± SD: 23 ± 8 y; 73 ± 9
kg; 1.78 ± 0.09 m; 23.0 ± 1.4 kg·m-2; VO2max: 47 ± 11
ml·kg-1·min-1) took part in a separate experiment to
determine intra-individual variation in response to an
oral glucose tolerance test, and did not perform HIT.
There were no significant differences in the age, height,
weight, BMI or VO2max between the two groups of sub-
jects. Subjects were informed of the experimental protocol
both verbally and in writing before giving informed con-
sent. Furthermore, all subjects were informed about how
potential life-style changes could affect the results of the
study, and were requested to maintain their normal diet
and levels of physical activity (apart from the training pro-
gram) throughout the duration of the study. The study
protocol was approved by the institutional Ethics Com-
mittee and conducted in accordance with the Helsinki
Declaration.
Experimental procedures
Baseline aerobic performance and health parameters were
determined over a 2-week period prior to commencement
of the training program.
Oral glucose tolerance test (OGTT)
Subjects refrained from performing any strenuous physi-
cal activity for 2 days prior to the OGTT, and attended the
laboratory having fasted overnight. Venous blood sam-
ples were collected by venepuncture before, and 60, 90
and 120 min after ingestion of 75 g glucose (Fisher Scien-
tific, Loughborough, UK) dissolved in 100 ml of water.
Plasma was separated by centrifugation (10 min at 1600
g) and stored at -20°C until analysis of glucose, insulin
and NEFA concentrations. Plasma glucose concentrations
were measured using an automatic analyzer (YSI
Stat2300, Yellow Spring Instruments, Yellow Spring, OH)
and plasma insulin concentrations were determined by
ELISA (Invitrogen, UK). Plasma insulin was measured
only for samples taken at 0, 60, and 90 min. Plasma NEFA
concentrations were determined by a colorimetric assay
(Wako Chemicals, Germany) using a modified protocol.
Briefly, 3.75 μl of plasma samples and standards of
known concentration were pipetted into a 96-well plate.
75 μl of colour reagent A was added to each well and incu-
bated at 37°C for 10 min. 150 μl of colour reagent B was
added and incubated for a further 10 min at 37°C. The
plate was then removed from the incubator and allowed
to cool to room temperature prior to the absorbance being
read at 550 nm. Coefficients of variation (CV) for dupli-
cate samples were 3% for glucose, 5% for insulin, and 8%
for NEFAs.Page 2 of 8
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On a separate occasion, subjects performed an exhaustive
incremental cycling test (Lode Excalibur Sport, Gronin-
gen, the Netherlands) to determine maximal power out-
put (Wmax) and maximal oxygen uptake capacity
(VO2peak) using an online gas analysis system (Sensor-
Medics, Bilthoven, the Netherlands). After cycling at 30 W
for 1 min, power output was increased by 30 W·min-1
until volitional exhaustion. VO2peak was determined as
the highest value achieved over a 20-s period.
Time trials
Endurance performance was determined to provide an
integrated physiological readout to facilitate comparison
of the present study with previous studies which provided
data from muscle biopsy samples [15]. Subjects per-
formed two self-paced cycling time trials in which they
were instructed to complete 250 kJ of work as fast as pos-
sible. The linear factor was chosen to produce a power
output corresponding to 75% of Wmax at a pedal rate of
90 rpm. No encouragement was given, and subjects were
blinded from information on time, power output and
pedal frequency. The amount of work (kJ) completed was
called out every 25 kJ. Time trials were spaced at least two
days apart. Although the first of the two pre-training trials
was mainly used as a familiarisation trial, the fastest time
achieved in the two trials was considered to best represent
the pre-training performance level and used in the analy-
sis (19 out of 25 subjects performed better in the second
trial than in the familiarisation trial).
Sprint interval training
The sprint training protocol was similar to that used pre-
viously by Burgomaster et al. [4,14]. Six sessions of sprint
interval exercise were spread over 14 days, with 1 or 2 days
of rest between each session. Each training session con-
sisted of 4–6 repeated 30-s all-out cycling efforts against a
resistance equivalent to 7.5% of body weight (Wingate
tests), with 4 min of recovery between sprints. During
recovery, subjects remained on the bike and either rested
or cycled at a low cadence without resistance. The number
of sprints increased from 4 during the first two sessions, to
5 in the third and fourth sessions, and 6 in the last two ses-
sions. Total time commitment was 17–26 min per ses-
sion, involving only 2–3 minutes sprint exercise.
Post-training assessment
A second OGTT was performed after completion of the
training program. In order to determine whether potential
changes were due to acute effects attributable to the last
training session, subjects were tested either two (n = 10),
or three (n = 6) days after the last bout of exercise. One
day after the second OGTT subjects performed a third
cycling time trial in order to determine changes in aerobic
performance.
Intra-individual variability in time trial performance and 
OGTT-response
In order to assess normal intra-individual variation in
response to an OGTT over a period of several weeks as
used in the present study, nine subjects performed an
identical protocol to the training group but without per-
forming the six training sessions. Coefficients of variation
(CV) for repeated measurements within individual sub-
jects were determined for baseline glucose and NEFA lev-
els, for glucose and NEFA area under the plasma curve,
and for time trial performance.
Calculations and statistical analysis
Area under the plasma curve (AUC) was calculated using
the conventional trapezoid rule. The Cederholm index,
which represents peripheral insulin sensitivity [16], was
calculated using the formula:
ISICederholm = 75000 + (G0-G120) × 1.15 × 180 × 0.19 × BW/
120 × Gmean × log (Imean)
Where BW is body weight, G0 and G120 are plasma glucose
concentration at 0 and 120 min (mmol·l-1), and Imean and
Gmean are the mean insulin (mU·l-1) and glucose
(mmol·l-1) concentrations during the OGTT.
All data are presented as means ± SEM. Plasma glucose,
insulin, and NEFA responses to the pre-training and post-
training OGTTs were analyzed using two-way repeated
measures ANOVA with post hoc Student Newman-Keuls
tests. Differences between pre-training and post-training
data for time trial performance, AUCs for plasma glucose,
insulin, and NEFA levels, and insulin sensitivity as meas-
ured by the Cederholm index were analyzed using paired
sample t-tests. Pearson's correlation coefficient was used
to assess bivariate correlations between baseline values of,
and changes in the variables performance, AUCs of glu-
cose, insulin, and NEFAs, and the Cederholm Index. Sig-
nificance was accepted at P < 0.05.
Results
Glucose responses
Fasting plasma glucose concentrations were unaltered
after 2 weeks of HIT. In the pre-training OGTT, plasma
glucose concentration was elevated 60 min after the 75 g
glucose bolus (Figure 1A; 0 min: 5.0 ± 0.1 v 60 min: 6.5 ±
0.4 mmol·l-1; P < 0.0001), but not post-HIT (Figure 1A; 0
min: 5.0 ± 0.1 v 60 min: 5.0 ± 0.2 mmol·l-1). The plasma
glucose area under the curve (AUC) was significantly
reduced post-training (Figure 1A: AUC pre 664 ± 103 v
AUC post 585 ± 65 mmol·min·l-1; P < 0.001).
Insulin responses
Fasting plasma insulin concentrations were unaltered
after 2 weeks of HIT. In the pre-training OGTT, plasmaPage 3 of 8
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Response to an oral glucose load pre- and post-HITFigure 1
Response to an oral glucose load pre- and post-HIT. Plasma concentrations and AUC for A: glucose, B: insulin and C: 
NEFAs. (*: P < 0.01 for 0 min v 60 min; †: P < 0.01 for pre v post).
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glucose bolus (Figure 1B; 0 min: 10.5 ± 1.6 v 60 min: 74.0
± 8.9 mU·l-1; P < 0.05). Post-training this increase was sig-
nificantly attenuated (Figure 1B; 0 min: 10.6 ± 1.6 v 60
min: 42.6 ± 6.0 mU·l-1; P < 0.01). Although plasma insu-
lin levels were still elevated 90 min after the 75-g glucose
bolus both pre- and post-training, levels were no longer
significantly higher than at 0 min (pre: 38.8 ± 6.3 mU·l-1;
post: 27.7 ± 2.7 mU·l-1). The plasma insulin AUC was sig-
nificantly reduced post-training (Figure 1B: AUC pre 4226
± 1912 v AUC post 2654 ± 1252 mU·min·l-1; P < 0.001).
Insulin sensitivity significantly improved following 2
weeks of HIT (Cederholm index: pre 80 ± 6 v post 98 ± 5
mg·l2·mmol-1·mU-1·min-1, P < 0.01).
NEFA responses
There was a trend towards a decrease in baseline plasma
NEFA concentrations following HIT (Figure 1C; pre: 350
± 36 μmol·l-1 v post: 290 ± 39 μmol·l-1, P = 0.058). In the
pre-training OGTT, plasma NEFA concentration was
decreased 60 min after the 75 g glucose bolus (Figure 1C;
0 min: 350 ± 36 μmol·l-1 v 60 min: 255 ± 48 μmol·l-1; P
< 0.01), and to a greater extent post-HIT (Figure 1C; 0
min: 290 ± 39 μmol·l-1 v 60 min: 153 ± 17 μmol·l-1, P <
0.001; pre 60 min: 255 ± 48 μmol·l-1 v post 60 min: 153
± 17 μmol·l-1 P < 0.05). The plasma NEFA AUC was sig-
nificantly reduced post-training (Figure 1C: AUC pre
31584 ± 13205 v AUC post 23370 ± 8630 μmol·min·l-1;
P < 0.001), whereas despite the decreased insulin AUC
post-training the incremental NEFA AUC was similar pre-
and post-training (pre: -12748 ± 2752 μmol·min·l-1;
post: -13513 ± 2541 μmol·min·l-1).
Physiological considerations
To bench-mark our results with recently published stud-
ies, we determined the impact of HIT on performance.
Work done in the 250-kJ time trial was significantly
increased by an average of 6% following 2 weeks of HIT
(mean difference: 75 s, 95% CI: 21–126 s; P < 0.01). At
baseline, the only physiological parameter which related
to a metabolic parameter, was aerobic capacity vs. NEFA
response to the OGTT (R2 = 0.43, P < 0.001). There was a
modest correlation between changes in glucose and insu-
lin AUC (R2 = 0.25, P < 0.05). Changes in performance did
not correlate with baseline values for, or changes in the
AUCs of glucose, insulin, and NEFAs, and insulin sensitiv-
ity as measured by the Cederholm index. We also consid-
ered whether the timing of the post-training assessment
impacted on the observed metabolic changes. Improve-
ments in glucose, insulin, and NEFA responses were simi-
lar whether assessed two or three days following the final
training session (mean reduction in glucose AUC: 2 d post
12 ± 10%, 3d post 19 ± 4%; insulin AUC: 2 d post 34 ±
9%, 3d post 38 ± 9%; NEFA AUC, 2d post 23 ± 21%, 3d
post 27 ± 9%).
Intra-individual variation in time trial performance and 
response to an OGTT
In subjects not performing the HIT program, no signifi-
cant differences between the first and second OGTTs were
observed for plasma glucose (AUC: 671 ± 47 v 659 ± 40
mmol·min·l-1) and NEFAs (AUC: 24035 ± 1611 v 22599
± 2544 μmol·min·l-1), nor for time trial performance
(1477 ± 214 v 1491 ± 245 s). Coefficients of variation for
the repeated measurements were 2.1% for the time trial,
4.9% and 7.0% for fasting glucose and NEFA concentra-
tions, and 8.1% and 8.2% for glucose and NEFA AUCs
respectively.
Discussion
While regular exercise training represents one of the most
powerful strategies to reduce the development of meta-
bolic disease in healthy adults [17], most adults fail to
meet current guidelines for participation [18]. These
guidelines largely focus on the time spent carrying out
moderately intense activity (or total energy expenditure),
typically require many hours of exercise each week and
can fail to modify risk factors relevant for disease preven-
tion [19]. In addition, as time commitment is perceived as
a major barrier, driving or contributing to low compli-
ance, then these guidelines may not be the most logical
approach for improving public health. In the present
study we demonstrate for the first time that only a few
minutes of high intensity interval exercise performed over
two weeks is required to substantially improve both insu-
lin action and glucose homeostasis in sedentary young
males. This is both a physiologically important observa-
tion and potentially useful as it highlights a preventative
intervention that could logically be implemented as an
early strategy to prevent age related development of cardi-
ovascular disease.
Interestingly, despite employing long-term training interven-
tions (2–16 months) the majority of studies investigating
classic aerobic [10,20-25] or strength training programs [26-
28] have observed only a reduction in insulin area under the
curve (AUC) in response to a glucose load following train-
ing, without a concomitant reduction in glucose AUC, indi-
cating only a partial improvement in insulin action.
Furthermore, walking based interventions may not reduce
risk factors in the target population where prevention is the
key objective [19]. Some longitudinal exercise studies have
shown reductions in glucose AUC [29-31], but post-training
OGTTs were performed within 24 hours of the last exercise
bout and therefore reflect the combined impact of acute and
chronic exercise [32]. In contrast, Hughes et al demonstrated
reduced glucose AUC in elderly subjects without a concomi-
tant change in insulin AUC [33].
The low volume, high intensity training utilized in the
current study significantly reduced both glucose AUC (-Page 5 of 8
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improved insulin action until at least day three after the
last exercise session. This was achieved without changes in
body weight, and with a weekly energy-'cost' of training of
~225 kcal during the first training week and ~275 kcal
during the second training week. This very modest
increase in calorie consumption is in stark contrast to the
~2000–3000 kcal·week-1 consumed during a typical aero-
bic training program [25,34]. This implies, but does not
prove, that the mechanism underpinning the benefits we
observed with HIT, may be distinct from those responsi-
ble for the more modest improvements in insulin action
with classic time-consuming aerobic training. While
much focus is being given to increasing calorie consump-
tion to ward off weight gain, it is clear that improving met-
abolic fitness may be just as important as limiting gains
body mass index.
Failure for insulin to adequately control blood glucose
following a meal is known as 'insulin resistance'. Skeletal
muscle is considered the major tissue responsible for the
uptake of glucose following a meal, or a glucose or insu-
lin challenge [35] such that it is entirely reasonable to
assume that the improvement in glucose and insulin
AUC observed in the present study reflected improved
muscle glucose uptake. The limiting step in glucose dis-
posal is considered to be its transport into the skeletal
muscle [6] and GLUT4 is the most abundant glucose
transporter in skeletal muscle. Increased GLUT4 concen-
tration with endurance training has been suggested to be
an important factor regulating insulin sensitivity [6,33].
Burgomaster et al. reported that skeletal muscle GLUT4
levels increase by ~20% after one week of HIT, and
remarkably remained elevated over 6 weeks of training
and a subsequent 6-week period of detraining [14].
Given the similarity between our study and the aerobic
performance improvement, protocols and subjects in the
Burgomaster et al studies, these studies should be com-
parable and thus an increase in GLUT4 may partly
explain our findings. However, increased GLUT4 con-
centration does not always fully explain training-
induced improvements in insulin sensitivity and key reg-
ulatory proteins down-stream in the insulin signalling
pathway are more activated in response to insulin fol-
lowing aerobic training [36]. HIT produces similar
changes in skeletal muscle markers of carbohydrate and
lipid metabolism to aerobic training [37], so it should be
investigated whether HIT also produces similar adapta-
tions of the insulin signalling pathway as seen following
traditional aerobic training [36].
Improved whole body glucose disposal following training
has been associated with an increase in insulin stimulated
glycogen synthesis [38]. HIT has at least two novel fea-
tures, firstly unlike walking or moderate intensity aerobic
training, it involves the activation of a large muscle mass
and secondly this is associated with a very high glycogen
breakdown-turnover. The combination of these two fac-
tors means that a greater proportion of muscle fibres will
need to replenish their carbohydrate stores, compared
with what would be encountered following moderate
intensity aerobic training. Muscle contraction under con-
ditions of metabolic stress (such as incurred during HIT)
results in very rapid glycogen degradation [49] and this
would almost certainly alter the binding of a variety of gly-
cogen associated proteins [40,41]. Thus we suspect that
remodelling of the glycogen pool, altering the molecules'
branching architecture [38], may well be important in reg-
ulating skeletal muscle insulin sensitivity following HIT.
Currently, high intensity muscle contraction is the only
feasible strategy for remodelling of the entire muscle gly-
cogen pool in humans.
Insulin sensitivity may also be regulated by plasma NEFA
concentration. Pharmacological lowering of plasma NEFA
levels has been shown to positively regulate insulin sensi-
tivity during an OGTT [39], whereas raising plasma NEFA
concentration, through lipid infusion, lowers glucose
infusion rate during peripheral insulinemia-euglycemia in
young men [40]. In contrast, exercise training has been
shown to have little or no effect on fasting plasma NEFA
concentration, insulin mediated lipolysis or NEFA release
during exercise [41-44]. In the present study, HIT was
associated with a 17% decrease in fasting plasma NEFA
concentration without a concomitant change in fasting
insulin. Furthermore, there was a 26% reduction in NEFA
AUC during OGTT following HIT despite a 37% reduction
in the plasma insulin AUC. This suggests that insulin was
able to inhibit lipolysis to a greater extent following HIT
and while these changes are more modest than those
observed with lipid powering drugs, the long terms bene-
fits may still be of significance.
Conclusion
We demonstrate for the first time that low volume, high
intensity interval exercise involving only ~250 kcal of
work, is sufficient to achieve significant improvements in
glycemic control in sedentary young adults. This study is
limited to the measurement of whole body insulin sensi-
tivity which makes the interpretation of our data incom-
plete. Analysis of tissue specific responses through biopsy
studies would enhance the present study by allowing
determination of the mechanisms involved in the
improvements observed at the whole body level. Never-
theless, our data and the findings by the Gibala lab
[4,37,45-49] suggest that current guidelines, with regards
to optimizing exercise prescription to yield the best health
outcomes, may not be optimal and certainly require fur-
ther discussion. Our findings warrant further studies
investigating the effectiveness of HIT in improving glyc-
emic control in healthy middle aged individuals at risk of
developing T2D and in patients with T2D.Page 6 of 8
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